<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092570</url>
  </required_header>
  <id_info>
    <org_study_id>D16-P03</org_study_id>
    <nct_id>NCT03092570</nct_id>
  </id_info>
  <brief_title>Manual Dexterity Control After Cerebellar Stimulation</brief_title>
  <acronym>MADECCS</acronym>
  <official_title>Assessment of Cerebellar Stimulation Effect on Motor Learning in Ageing Population and Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier St Anne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier St Anne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the putative advantages of cerebellar stimulation on motor learning
      abilities of stroke patients. In order to have a control group to refer to, the effect of
      cerebellar stimulation on healthy young and old participants will also be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebrovascular accidents (CVA) are the first cause of acquired disability in France. Despite
      rehabilitation interventions, a great proportion of patients suffers from motor disability in
      the upper limb. Recently, several studies have shown that post CVA patients exhibit great
      neural plasticity as a direct consequence of their condition.

      Interestingly, the transcranial direct current stimulation (tDCS) is a non-invasive electro
      stimulation technique that allows for a modulation of cerebral activity. It has been shown
      that when applied to the cerebellum, tDCS increases learning performances of healthy
      subjects. Yet, motor rehabilitation after a CVA highly relies on motor (re)learning. The
      cerebellar tDCS thus appear as a promising method to enhance the performance of post-CVA
      motor learning and consequently the benefits of post-CVA rehabilitation.

      The current study aims to promote the post CVA neural plasticity by using the tDCS in order
      to enhance motor learning of the upper limb.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Force control</measure>
    <time_frame>Day 1</time_frame>
    <description>Measurement in Newton of the force applied by each finger.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Force control</measure>
    <time_frame>Day 2</time_frame>
    <description>Measurement in Newton of the force applied by each finger.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Force control</measure>
    <time_frame>Day 3</time_frame>
    <description>Measurement in Newton of the force applied by each finger.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Force control</measure>
    <time_frame>Day 10</time_frame>
    <description>Measurement in Newton of the force applied by each finger.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overflow</measure>
    <time_frame>Day 1</time_frame>
    <description>Measurement in ms of the involuntary finger movements.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overflow</measure>
    <time_frame>Day 2</time_frame>
    <description>Measurement in ms of the involuntary finger movements.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overflow</measure>
    <time_frame>Day 3</time_frame>
    <description>Measurement in ms of the involuntary finger movements.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overflow</measure>
    <time_frame>Day 10</time_frame>
    <description>Measurement in ms of the involuntary finger movements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Moberg Pick-up Test</measure>
    <time_frame>Day 1</time_frame>
    <description>Assessment of the functionality of the hand. One score will be given at the end of the test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Moberg Pick-up Test</measure>
    <time_frame>Day 2</time_frame>
    <description>Assessment of the functionality of the hand. One score will be given at the end of the test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Moberg Pick-up Test</measure>
    <time_frame>Day 3</time_frame>
    <description>Assessment of the functionality of the hand. One score will be given at the end of the test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Moberg Pick-up Test</measure>
    <time_frame>Day 10</time_frame>
    <description>Assessment of the functionality of the hand. One score will be given at the end of the test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Day 1</time_frame>
    <description>Assessment of the upper limb mobility. One score will be given at the end of the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Day 2</time_frame>
    <description>Assessment of the upper limb mobility. One score will be given at the end of the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Day 3</time_frame>
    <description>Assessment of the upper limb mobility. One score will be given at the end of the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test</measure>
    <time_frame>Day 10</time_frame>
    <description>Assessment of the upper limb mobility. One score will be given at the end of the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Finger time release</measure>
    <time_frame>Day 1</time_frame>
    <description>Time needed to release the finger force when needed (in ms).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Finger time release</measure>
    <time_frame>Day 2</time_frame>
    <description>Time needed to release the finger force when needed (in ms).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Finger time release</measure>
    <time_frame>Day 3</time_frame>
    <description>Time needed to release the finger force when needed (in ms).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Finger time release</measure>
    <time_frame>Day 10</time_frame>
    <description>Time needed to release the finger force when needed (in ms).</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>tDCS Post-CVA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will get a 20min stimulation at a maximal intensity of 2mA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Post-CVA</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The tDCS will be placed as for the Experimental group and will last 30 seconds at the beginning of task</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Young Healthy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will get a 20min stimulation at a maximal intensity of 2mA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Young Healthy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The tDCS will be placed as for the Experimental group and will last 30 seconds at the beginning of task</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Older Healthy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will get a 20min stimulation at a maximal intensity of 2mA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Older Healthy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The tDCS will be placed as for the Experimental group and will last 30 seconds at the beginning of task</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>With stimulation</intervention_name>
    <description>ramp stimulation from 0 to 2 mA followed by 20 minutes of stimulation at 2mA while practicing during 3 of the 4 sessions</description>
    <arm_group_label>tDCS Post-CVA</arm_group_label>
    <arm_group_label>tDCS Young Healthy</arm_group_label>
    <arm_group_label>tDCS Older Healthy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>No stimulation</intervention_name>
    <description>ramp stimulation from 0 to 2 mA followed by 30 sec of stimulation at 2mA.</description>
    <arm_group_label>Sham Post-CVA</arm_group_label>
    <arm_group_label>Sham Young Healthy</arm_group_label>
    <arm_group_label>Sham Older Healthy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Right-handed

          -  Affiliated to the French health insurance or similar organisation

          -  Signed informed consent

          -  Clinical examination

        For &quot;Post-AVC patients&quot; :

          -  at least 18 years old

          -  completed the Moberg Pick-up test with a minimum score of 20 secondes For &quot;Young
             healthy&quot; group

          -  18 = or &gt; years = or &lt;30 For &quot;Older healthy&quot; group

          -  50 &gt; or = years = or &lt; 80

        Exclusion Criteria:

          -  Metallic implant in the head

          -  Pacemaker, or other electronic implanted devices

          -  Other central neurological disease

          -  Pregnancy, breast feeding

          -  Previous history of neurosurgery or seizures or 1st degree relative with history of
             seizures

          -  History of medical neurological or psychiatric disorders

          -  Participation to another study using cerebral stimulation

          -  History of bi-polar or recurring depressive disorders

          -  Planned carotid revascularization, severe caridac disease

          -  Kidney failure (transaminase &gt; 2 times normal value)

          -  Other invalidating condition or deficiency interfering with the study

        For &quot;Post-AVC patients&quot; :

          -  NIHSS score &gt; 20

          -  Cerebellar ischemic CVA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence COLLE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHSA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marion Verneau, PhD</last_name>
    <phone>+33140788663</phone>
    <email>mverneau@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie GODARD</last_name>
    <phone>00 33 1 45 65 77 28</phone>
    <email>marie.godard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche Clinique (CRC) - CHSA</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Macarena CUENCA, MD</last_name>
      <email>m.cuenca@ch-sainte-anne.fr</email>
    </contact>
    <contact_backup>
      <last_name>Cecile Bergot</last_name>
      <phone>00 33 1 45 65 84 90</phone>
      <email>c.bergot@ch-sainte-anne.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Macarena CUENCA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Physique et Rédaptation</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florence COLLE, MD</last_name>
      <phone>00331 45 65 62 00</phone>
      <email>f.colle@ch-sainte-anne.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marie GODARD</last_name>
      <phone>00 33 1 45 65 77 28</phone>
      <email>marie.godard@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Florence COLLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2017</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Motor learning</keyword>
  <keyword>stroke</keyword>
  <keyword>tDCS</keyword>
  <keyword>upper limb</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

